Valuation: Artivion, Inc.

Market Cap 1.23B 1.08B 998M 918M 1.73B 119B 1.76B 11.93B 4.68B 58.11B 4.62B 4.52B 200B P/E 2026 *
303x
P/E 2027 * 62.3x
Enterprise Value 1.23B 1.08B 998M 918M 1.73B 119B 1.76B 11.93B 4.68B 58.11B 4.62B 4.52B 200B EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.28x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day+1.24%
1 week+5.58%
Current month+12.91%
1 month+19.73%
3 months-34.61%
6 months-41.69%
Current year-44.38%
1 week 23.18
Extreme 23.18
26.06
1 month 20.08
Extreme 20.085
26.06
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer 69 2021-02-28
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Date Insider Type Main position Quantity % Market Cap.
6/11/26 Fiscal year

General Counsel

132,003 0.2719%
6/2/26 Others

Director

-12,650 0.0261%
6/1/26 Other

General Counsel

104,260 0.2148%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%+5.58%-16.79%+49.32% 1.22B
+0.97%+10.37%-17.80%-9.09% 175B
+0.11%-0.34%-7.05%-6.78% 106B
-1.27%-0.70%+3.80%+57.17% 59.91B
+1.01%+0.29%+42.21%+63.19% 51.95B
-2.33%+0.42%-13.63%-41.35% 43.58B
-2.29%-4.19% - - 33.65B
-1.25%-0.86%-9.77%-42.07% 29.58B
-1.65%-2.05%+67.06%-6.98% 25.31B
-1.55%-1.19%-4.93%-6.81% 21.23B
Average -0.67%+1.83%+4.79%+6.29% 54.83B
Weighted average by Cap. -0.21%+2.76%-1.48%+2.10%

Financials

2026 *2027 *
Net sales 486M 426M 394M 362M 684M 46.89B 695M 4.71B 1.85B 22.94B 1.83B 1.79B 79.04B 540M 473M 437M 402M 759M 52.05B 771M 5.23B 2.05B 25.47B 2.03B 1.98B 87.75B
Net income 4.4M 3.86M 3.56M 3.28M 6.19M 424M 6.29M 42.63M 16.71M 208M 16.52M 16.16M 715M 22.59M 19.8M 18.3M 16.83M 31.76M 2.18B 32.27M 219M 85.78M 1.07B 84.81M 82.96M 3.67B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
26-07-20 $25.37 +1.24% 460,286
26-07-17 $25.06 -2.60% 535,319
26-07-16 $25.73 +5.84% 878,847
26-07-15 $24.31 +5.10% 533,918
26-07-14 $23.13 -3.75% 400,931
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
25.37USD
Average target price
42.00USD
Spread / Average Target
+65.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock